Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Surgery Partners
SGRY
Surgery Partners
Outpatient Shifts And CMS Changes Will Expand Surgical Potential
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
26 May 25
Updated
15 Aug 25
2
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$31.00
26.5% undervalued
intrinsic discount
15 Aug
US$22.80
Loading
1Y
-21.4%
7D
-3.6%
Author's Valuation
US$31.0
26.5% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$31.0
26.5% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-243m
4b
2014
2017
2020
2023
2025
2026
2028
Revenue US$4.3b
Earnings US$168.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.95%
Healthcare Services revenue growth rate
0.27%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.72%
Calculation
US$168.41m
Earnings '28
x
29.86x
PE Ratio '28
=
US$5.03b
Market Cap '28
US$5.03b
Market Cap '28
/
130.15m
No. shares '28
=
US$38.64
Share Price '28
US$38.64
Share Price '28
Discounted to 2025 @ 7.66% p.a.
=
US$30.96
Fair Value '25